Nike, Inc. (NKE)
NYSEConsumer DiscretionaryFootwear & AccessoriesSnapshot 2026-07-07
$43.20-0.33%
Close 2026-07-07 · 1-day change
Reading NKE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track NKE free→NYSEConsumer DiscretionaryFootwear & AccessoriesSnapshot 2026-07-07
Reading NKE? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track NKE free→Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Apparel, Accessories & Luxury Goods is in contraction. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Selling and administrative expenses near $16.1 billion: metric not reported.
View ThesisRevenue is contracting — down about 3% over the past year.
View GrowthMiddle-of-the-pack quality for its industry.
View QualityManagement screens strong on earnings delivery, margins.
View ManagementExpectations look reasonable — what the market is pricing in sits in line with or below what analysts forecast.
View ValuationThis stock is volatile — it swings about 1% on a typical day and fell roughly 48% in its worst 12-month stretch.
View RiskNike's growth has to keep compounding to justify the price, especially as sales grow near consensus levels with revenue down 1% year over year. The latest earnings beat, with an EPS surprise of 554.5%, indicates strong recent financial performance. Currently, it trades at 28× P/E versus a peer median of 23×, suggesting that the price reflects less growth than forecasted. A specific risk is the potential for a guidance cut, which our model puts at an 11% probability for the next quarter. Peer multiples imply a price roughly in line with where it trades. This read is provisional.
Trailing returns as of 2026-07-07. NKE is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 39 analysts currently covering NKE (as of Jul 2026).
Based on 17 Wall Street analysts offering 12-month price targets for NKE in the last 4 months.
A consensus fair price across 11 valuation methods, at three horizons. Current price $43.20. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Apparel, Accessories & Luxury Goods — fair value, gap to price, and forward P/E.
Threatens: Win Now actions to improve business
Q4 performance raises concerns about growth trajectory.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-07-07. EPS is implied from price ÷ P/E. Not investment advice.
Current $43.20
The last 12 months of price, then the range of analyst 12-month targets from today’s $43.20.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Legal issues could distract from growth initiatives.
Lawsuit could impact brand and sales.
CEO's comeback is jeopardized by internal issues.
Threatens: Win Now actions to improve business
Indicates reliance on tariffs rather than demand for growth.
Positive analyst rating supports growth objectives.
Negative rating raises concerns about growth potential.
Trademark lawsuit could impact brand and financials.